
|Articles|December 31, 2015
Michael Mauro Discusses Therapy-Free CML Remission
Author(s)Michael Mauro, MD
Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses cessation of chronic myeloid leukemia (CML) treatment for therapy-free remission.Â
Advertisement
Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses cessation of chronic myeloid leukemia (CML) treatment for therapy-free remission.Â
Mauro says patients with CML are often concerned about how long they have to stay on medication.
Newsletter
Knowledge is power. Don’t miss the most recent breakthroughs in cancer care.
Advertisement




















